pharma news today glp-1 obesity drugs Dozens of new are coming: these are the ones to watch Chart: 1 in 8 Americans

Patient-reported outcomes are superior in patients with type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

I have seen patients recover

We focus on bioavailability because it is the only way to ensure the ingredients we source actually reach their destination

and Katsilambros, N., Effect of long-term hydroxytyrosol administration on body weight, fat mass and urine metabolomics: a randomized double-blind prospective human study

In some cases, employers can access discounts or rebates to lower the cost of GLP-1s, but Midlam noted implementing certain utilization management strategies could disqualify businesses from rebates

You still need to protect muscle